Co-administration of MVA NP+M1 and the Viroflu Seasonal Flu Vaccine

• Research type

  Research Study

• Full title

  A phase I study to determine the safety and immunogenicity of co-administration of the candidate influenza vaccine MVA-NP+M1 and the Viroflu® seasonal influenza vaccine

• IRAS ID

  138386

• Contact name

  Adrian Hill

• Contact email

  adrian.hill@ndm.ox.ac.uk

• Sponsor organisation

  Oxford University Hospitals NHS Foundation Trust

• Eudract number

  2013-003569-32

• ISRCTN Number

  n/a

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  13/SC/0498

• Date of REC Opinion

  28 Oct 2013

• REC opinion

  Favourable Opinion